English
Français

Products

  • Mouth mucous lesions
  • Xerostomia
  • Bedsore prevention
  • Hair loss
  • Musculo-skeletal pain
  • Heavy legs
  • Others

Mouth mucous membranes lesions

Buccagel

BUCCAGEL® : PROTECTIVE ORAL GEL for topical application.

The physical and biomechanical properties of O.G.T. make BUCCAGEL®,
particularly suitable for the treatment of lesions of the oral mucosa :

  • Mouth ulcers
  • Lesions related to complete or partial dentures
  • Sensitive gums: inflammation and bleeding

The lubricating property of O.G.T. allows painless massage of the lesions to which a protective film adheres forming a “shield” against aggressions (food, contact with the denture, etc.).

Presentation : tube of 5 ml en France.

BUCCAGEL® is distributed in the European Community under the regulatory status of a Medical Device Class I complying with the requirements of Directive 93/42/EEC.

BUCCAGEL® is distributed in France by TONIPHARM Laboratory.

BUCCAGEL® is distributed all over Europe under different trade names.


Mouth mucous membranes lesions

Xerostomia

Aequasyal

ÆQUASYAL® is a lubricating and protective mouth spray solution indicated for the treatment of xerostomia or dry mouth.

ÆQUASYAL® oral spray reduces feeling of dry mouth and improves the associated symptoms: inflammation of the oral mucosa, difficulties of deglutition, mastication, etc.

LPPR : 65% (reimbursement by French Social Security).

Presentation : 40 ml bottle for 2 months of treatment.

In Europe, ÆQUASYAL® is a Medical Device Class I, complying with the requirements of Directive 93/42/EEC.

In the U.S.A., ÆQUASYAL® is an FDA approved Medical Device under the 510 (k) regulation.

ÆQUASYAL® is distributed in France by Laboratoire EISAI.


Xerostomia

Prevention of pressure ulcer and treatment of pressure erythema

Ulcilène

ULCILENE® protective solution is indicated in the prevention of pressure ulcer and the treatment of pressure erythema (warning lesion).

ULCILENE® is an O.G.T. solution enriched with vitamin A and Omega 3 essential fatty acids.

ULCILENE® restores the hydro lipid protective film of the skin, limits transcutaneous water loss, facilitates restoration of normal blood microcirculation, thereby promoting cell turnover and preventing pressure ulcer.

ULCILENE® must be applied locally by gentle massage (with finger tip weight) to risk zones. Massage is not painful.

ULCILENE® is a Medical Device Class I, complying with the requirements of Directive 93/42/EEC.

Presentation : 20 ml spray bottle.


Prevention of pressure ulcer and treatment of pressure erythema

Male and female alopecia

SILICIUM 44

The M-44® and SILICIUM 44® ranges are composed of 2 products :

  • a lotion containing a combination of O.G.T. and a high concentration of organic silicon
  • a shampoo

Once daily application of the lotion is sufficient.

M-44® and SILICIUM 44® control hair loss in less than 8 weeks. Hair do not need to be washed after application.

M-44® and SILICIUM 44® are marketed in France and in the world under the Cosmetic Legislation.

Presentation :

  • Lotion : 70 ml bottle for 3 week of treatment
  • Shampoo : 150 ml bottle

Distributed in pharmacies and parapharmacies


Male and female alopecia

Musculo-skeletal pain and inflammation

Oxyflex

OXYFLEX®

Arthritis, rheumatic pain, muscle pain, etc.

OXYFLEX® is a massage cream containing 20% O.G.T.. It is indicated for the relief of musculo-skeletal pain and inflammation.

OXYFLEX® is distributed in the U.S.A. by TRUSOLUTIONS Corporation under the Cosmetic Legislation.

OXYFLEX® will soon be transposed to the U.S. regulations on pharmaceutical "monograph products" in the regulatory context of the Federal Register.

OXYFLEX® can be distributed in Europe as a Medical Device.


Musculo-skeletal pain and inflammation

 

Painful and leavy legs

venoxyl

VENOXYL®, leg care

Prolonged exposure to heat (during summer, heating, etc.) and long standing are harmful to legs venous circulation, generating pain and severe discomfort.

O.G.T. stimulates superficial blood flow, providing immediate relief of tired legs or “heavy” legs.

Marketing license granted to Laboratoire EFFISCIENCE in France.


Painful and heavy legs

 

 

Other products ready to be launched

The following O.G.T. formulations, validated by significant clinical trials, are ready to be commercialized :

topical treatment

  • sunburn, erythema,
  • chilblains, cold feet, cold hands,
  • premenstrual breast pain, mastodynia,
  • superficial contusions, ecchymoses,
  • external haemorrhoids,

Laboratoires CARILENE can formulate and register a medical device for
each of these indications, which will allow immediate marketing in the EEC.